COVID-19

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.cdc.gov/coronavirus/

Get the latest research information from NIH: https://www.covid19.nih.gov

Meet the DCCPS New and Early Stage R01 Investigators

  • Marc A. Adams, Ph.D., M.P.H.
    Arizona State University - Tempe
    Behavioral Scientist and Epidemiologist

    Early in my career I discovered the world outside of the skin was just as complex and interesting as the one inside of the skin. That moment led me down a path of discovery of the principles of behavior change in our macro- and micro-environments and how these mechanisms influence preventive behaviors for chronic disease, such as physical activity.
  • David H. Adler, M.D., M.P.H.
    University of Rochester
    Emergency Physician and Clinical Researcher

    I have always believed that the emergency department environment presents a tremendous opportunity to advance preventive care, given the particular vulnerability of our patient population.
  • Tomi F. Akinyemiju, Ph.D.
    Duke University
    Social and Molecular Cancer Epidemiologist

    When I realized that the social environment can and does 'get under the skin' to influence biological mechanisms important for cancer, and thus, can be modifiable
  • Oguzhan Alagoz, Ph.D., M.S.
    University of Wisconsin - Madison
    Operations Researcher and Healthcare Analyst

    My ah-ha moment for this work is when I saw that the incidence of thyroid cancer has increased dramatically, whereas mortality rates remained more or less the same over the last several decades.
  • Tamar M. Antin
    Pacific Institute for Research and Evaluation
    Critical Public Health Researcher

    Critical public health perspectives are essential for explaining the tremendous inequities in health that disproportionately burden marginalized populations.
  • Allison J. Applebaum, Ph.D.
    Memorial Sloan Kettering Cancer Center
    Clinical Psychologist and Psychosocial Oncology Researcher

    After a decade of working with caregivers of patients with all sites and stages of cancer across the entire caregiving trajectory, it became clear to me that caregivers have become the invisible backbone of our healthcare system. These clinical experiences, and my own caregiving journey, inspired my work to support caregivers, to help them engage in caregiving without personal detriment, and to assist them in enhancing and sustaining well-being, resilience, and growth in the face of suffering
  • Hoda Badr, Ph.D.
    Icahn School of Medicine at Mount Sinai
    Social/Health Psychologist

    My mother was diagnosed with cancer and ultimately died from her disease. That experience showed me how fragile and resilient family relationships can be and how the cancer experience affects family members in different ways. I also realized how few programs exist to support and empower families through this difficult time and resolved to try to change that reality.
  • Steffani R. Bailey, Ph.D.
    Oregon Health & Science University
    Tobacco Treatment and Health Services Researcher

    While working on explanatory smoking cessation trials as a postdoctoral fellow, we had to exclude people with certain comorbidities that are quite common among those who smoke. I realized that I wanted my own research career to focus on real-world patients in real-world clinical settings. My goal is to increase access to, and utilization of, effective smoking cessation interventions in health care settings that serve populations disproportionately affected by tobacco use.
  • Kirsten Beyer, Ph.D., M.P.H., M.S.
    Medical College of Wisconsin
    Health and Medical Geographer

    Growing up, I was fascinated by the social justice movements of the 1960's and sometimes felt that I had been dropped into the global timeline several decades too late. My research focus on health disparities grew from my realization that there were plenty of problems, rooted in social injustice, to be solved in my own timeline.
  • Jiang Bian, Ph.D.
    University of Florida
    Data Scientist/Researcher

    Cancer research (and any scientific research in general) is fueled by data, and is therefore dependent on us continuing to pursue the effective acquisition, management, and subsequent uses of increasingly detailed multi-level, multi-domain data for scientific inquiry.
  • Alexandra Binder, Sc.M., Sc.D.
    University of Hawaii at Manoa
    Epigenetic Epidemiologist and Cancer Researcher

    We may not get to choose the genes we inherit, but by modifying our exposures and behaviors, we may be able to influence the regulation of our genes to shape our healthspan and lifespan.
  • Ulrike Boehmer, Ph.D.
    Boston University
    Social Scientist

    When some of my friends were diagnosed and dying of cancer, there was little awareness of the fact that the experiences of LGBT individuals might be different from that of heterosexual individuals because their cancer diagnoses were considered unrelated to sexual behavior. This led me to focus my research on individuals with cancer who are facing additional challenges due to their sexual and gender minority status.
  • Patrick S. Calhoun
    Duke University
    Clinical Psychologist and Health Services Researcher

    We often spend too much of our time developing the next best possible treatment without spending enough time thinking about how we are going to reach the people who need it most. Mobile health technologies are exciting because they provide a platform to increase the reach of intensive behavioral interventions, and have great potential to increase the impact of smoking cessation treatment.
  • William A. Calo, Ph.D., J.D.
    Penn State Health Milton S. Hershey Medical Center
    Implementation Scientist and Health Services Researcher

    With the explosion of health misinformation and disinformation surrounding vaccines, there is a tremendous need to deliver best-practice communication to improve HPV vaccine confidence and uptake. As an implementation scientist, my research focuses on effectively implementing research-tested interventions to prevent HPV-related cancers.
  • Lisa Carter-Harris, Ph.D.
    Memorial Sloan Kettering Cancer Center
    Behavioral Scientist with a clinical background as an Adult Nurse Practitioner

    My patients at risk for and living with lung cancer inspire me to do this work, but, more importantly, all of the patients who have shared their stories of experiencing stigma inspire me to improve patient-clinician discussions, so that no patient feels shame or blame.
  • Luis G. Carvajal Carmona, Ph.D.
    University of California - Davis
    Cancer Geneticist and Epidemiologist

    I remember when my postdoc came to my office with exome sequencing results to tell me that we only found two PALB2 mutations and remember thinking "but PALB2 has never been associated with gastric cancer." We went on to follow up and replicate the findings and ended up reporting, for the first time, the important role of PALB2 and other homologous recombination genes in gastric cancer risk. This study also served as the foundation to successfully secure my first R01.
  • Herta H. Chao, M.D., Ph.D.
    Yale University
    Medical Oncologist and Clinical Researcher

    After 3 years on androgen deprivation therapy for prostate cancer, one of my patients - a highly functional individual who was working in the development of medical devices and a Vietnam Veteran who was exposed to Agent Orange - had the courage to tell me that he felt the hormone shots were "frying" his brain. However, he scored well on commonly used neuropsychological tests. This patient's experience made me realize that we needed better tools to assess the cognitive impact of cancer treatment.
  • Mary E. Charlton, Ph.D.
    University of Iowa
    Cancer Health Services Epidemiology Scientist/Researcher

    My ah-ha moment came when I realized that many cancer care providers in rural Iowa hospitals didn't know about the Iowa Cancer Registry or the data we collect from them; and since they weren't asking us for data, I wondered how they could know how they were doing in terms of quality of care. I wanted to help them understand the power of the data and create an infrastructure for quality improvement and monitoring.
  • Ting-Yuan Cheng, Ph.D.
    University of Florida
    Cancer Epidemiologist

    I was profoundly influenced by the obesity pandemic in a global scale and its disproportional consequence in minority and underserved populations.
  • Philip Chow, Ph.D.
    University of Virginia
    Behavioral and Digital Health Scientist

    The purpose of research is ultimately to inform action. As a scientist initially trained to investigate the theoretical underpinnings that govern human emotion and behavior, I quickly discovered, as a postdoc, the need to conduct theoretically sound yet translatable research that could immediately and directly benefit individuals in need. I have been committed to that cause ever since.
  • Carrie H. Colla, Ph.D.
    Dartmouth College
    Health Economics and Policy Researcher

    Disparities in access to care for cancer patients can fall along the lines of race, ethnicity, and geography. Understanding how these characteristics intersect, the mechanisms through which the disparities occur, and the effects of policy levers that might be used to alleviate the disparities are key to improving outcomes for all patients.
  • Vivian Colon-Lopez, Ph.D., M.P.H.
    University of Puerto Rico Comprehensive Cancer Center
    Cancer Control and Population Scientist/Researcher

    After completing my doctorate in the US, my goal was to return to Puerto Rico, to have a direct impact on research, capacity and mentorship. As a junior investigator, I documented significant cancer disparities in Puerto Ricans. Years later, I am committed to strengthening a research platform on health disparities and to moving forward the development and implementation of culturally sensible evidence-based interventions, as well as policy and programmatic efforts for cancer control in the island.
  • Jennifer J. Cornacchione Ross, Ph.D.
    Wake Forest University Health Sciences
    Communication and Tobacco Regulatory Scientist/Researcher

    During graduate school, I became passionate about doing research to inform policy and regulations to improve people's health and well-being; doing this work within tobacco prevention and control, specifically, is both personally relevant and scientifically interesting and challenging.
  • Michele L. Cote
    Wayne State University
    Cancer Molecular Epidemiology Researcher

    At Karmanos Cancer Institute and Wayne State University, I see health disparities on a daily basis and have the unique opportunity to carry out research seeking to reduce the detrimental effects of these disparities in underserved populations.
  • Ana-Paula Cupertino, Ph.D.
    University of Kansas Medical Center
    Social Behavioral Researcher focused on addressing cancer disparities faced by Latinos by developing mobile health tools to be implemented in the context of community-based infrastructure

    I have been fascinated with the opportunity to translate my smoking cessation mobile research interventions into business models to increase access to Latino smokers in the U.S., Mexico and Brazil.
  • Pinkal Desai, M.D.
    Weill Cornell Medical College
    Cancer Epidemiologist and Physician Scientist/Researcher

    As a physician treating hematologic malignancies, I personally saw the devastating impact of hematologic cancers in my patients, and many patients would ask me how they could have prevented these cancers. The literature was severely lacking in this field, and this motivated me to combine my skills as a cancer epidemiologist and clinician to study early detection and prevention strategies for hematologic malignancies.
  • Katie A. Devine, Ph.D., M.P.H.
    Rutgers Cancer Institute of New Jersey
    Behavioral Scientist

    Cancer diagnosis and treatment during young adulthood interferes with normal developmental tasks across all life domains, yet there are very few evidence-based interventions to address the unique concerns of this group. My goal is to find ways to help these young adults thrive.
  • Michaela A. Dinan, Ph.D.
    Duke University
    Oncology Health Services Researcher

    A profound influence has been my personal experience with family members and loved ones battling cancer, and seeing how much variation in care there can be within the U.S. My research focuses largely on understanding how we as a population are affected by these variations in care and the inequitable use of emerging medical technologies.
  • James N. Dionne-Odom, Ph.D., R.N., A.C.H.P.N., F.P.C.N., F.A.A.N
    University of Alabama at Birmingham
    Palliative Care Nurse Scientist

    As an ICU nurse for over 10 years, I saw first-hand how excruciatingly difficult it was for families to witness someone close to them unconscious, seriously ill, and connected to machines, who were overwhelmed and underprepared with having to make extraordinarily difficult end of life decisions. I realized that families need to be trained and prepared much earlier on in the skills needed to be resilient in these difficult moments.
  • Michael S. Dunbar, Ph.D.
    RAND Corporation
    Behavioral Scientist

    In the past decade, we've seen dramatic changes in the policy and retail landscapes for both nicotine and cannabis products. Understanding how people are using specific types of products separately and in combination in daily life has critical implications for gauging potential risks and for informing new approaches to protect public health in a world where people have ready access to a staggering array of different products.
  • Tanya L. Eadie, Ph.D.
    University of Washington
    Speech-Language Pathologist and Behavioral Scientist

    Disruptions to one's voice and speech transcend voice quality or understandability; they impact the ability of individuals to participate in a variety of life roles and responsibilities, to form relationships, and ultimately how they identify themselves as unique human beings.
  • Susan S. Eggly
    Wayne State University
    Communication Scientist and Health Behavior Researcher

    I have always been passionate about better understanding how interpersonal communication, especially between people from different social groups, affects how people think and behave. This passion drives my work to better understand and improve patient-physician communication and healthcare in the context of racial disparities and cancer treatment.
  • Diane K. Ehlers, Ph.D.
    University of Nebraska Medical Center
    Behavioral Scientist

    My postdoctoral training opened my eyes to interdisciplinary, comprehensive frameworks of physical activity's influence on quality of life-most specifically, ones that include cognitive function as a mechanism of well-being. During my training I had the opportunity to work on two clinical exercise trials - one in aging and one in breast cancer survivorship. These experiences motivated me to develop new research questions related to physical activity and cognitive function in cancer.
  • W Douglas Evans, Ph.D.
    George Washington University
    Digital Health Scientist/Researcher

    I had an epiphany when I realized that everyone was using text messages for everything: Why couldn't we use them to promote healthy behaviors?
  • Amanda Fallin-Bennett, Ph.D., R.N.
    University of Kentucky
    Nurse Researcher

    After growing up in rural Kentucky, I moved to California and was struck by the stark geographic disparity in tobacco control policies, and became passionate about closing the gap in rural, southern states.
  • Jesse R. Fann, M.D., M.P.H.
    University of Washington
    Psychiatrist and Health Services Researcher

    After many years of caring for people with cancer, I continue to be motivated by both their resilience and the enormous psychosocial challenges they must overcome. My goal is to combine clinical and technological innovation to positively impact the health care and quality of life of the many people suffering from cancer and mental illness.
  • Farhood Farjah, M.D.
    University of Washington
    Thoracic Surgeon and Clinical Researcher

    There are few things as profound as witnessing a disease affect individuals in your clinical practice, people you study, and your friends and family - for these reasons I choose to dedicate my energy to improving care and outcomes for individuals with an incidentally (not screen) detected lung nodule.
  • Robert J. Ferguson, Ph.D.
    University of Pittsburgh
    Clinical Health Psychologist and Cancer Survivorship Researcher

    In early surveys of the cognitive rehabilitation outcomes literature, I recognized that focusing solely on enhancing memory performance as assessed by neurocognitive testing was incomplete; cognitive abilities - e.g., memory, attention, emotion regulation - exist to perform valued activities in daily life. Using effective behavior change methods to enhance performance in daily activity was key to quality of life and functional improvement, regardless of the cognitive change one experiences after cancer.
  • Lila J. Finney Rutten, Ph.D., M.P.H.
    Mayo Clinic
    Social and Behavioral Scientist

    In building a program of research in population health science in a clinical setting, I realized that the true value of my expertise and experience in behavioral science could be leveraged in the clinical setting through implementation science efforts aimed at improving adoption of evidence-based cancer prevention and control strategies.
  • Lauren M. Fishbein, M.D., Ph.D.
    University of Colorado - Denver
    Physician Scientist and Translational Researcher

    I first read about the promise of the human genome project and its potential for personalized medicine to predict and treat cancer and other diseases when I was a college student in the mid 1990s. I became fascinated with precision medicine and sought to pursue an MD, PhD degree to study cancer genetics.
  • Nancy Fleischer, Ph.D., M.P.H.
    University of Michigan - Ann Arbor
    Social Epidemiologist

    As a Peace Corps Volunteer many years ago, I served in two vastly different countries: the Solomon Islands and Kazakhstan. By living in these two disparate places I became keenly aware of how place affects health - through culture, environmental conditions, and policies. I have carried these concepts with me into my research career, trying to understand ways that the social and policy environments affect health and health disparities.
  • Randi E. Foraker, Ph.D., M.A.
    Washington University in St. Louis
    Chronic Disease Researcher

    Through this work I realized that chronic diseases should not be treated in a vacuum, and that electronic health record-based tools could revolutionize survivorship care by allowing an oncologist to quickly assess survivor cardiovascular health and coordinate appropriate care.
  • David O. Francis, M.D., M.S.
    University of Wisconsin - Madison
    Otolaryngologist and Health Services Researcher

    I became aware of the term "Furor Medicus" and have come to recognize it as a principal problem in medicine today. It relates to two factors: the level of uncertainty within the clinician and the level of insistence by the patient to do something. This combination is a recipe for too much testing, reinforced uncertainty, and too much treatment. Sometimes it's better to do less.
  • Anna Helena Furberg-Barnes, Ph.D.
    Memorial Sloan Kettering Cancer Center
    Molecular Epidemiologist

    It's important to me to conduct research studies that are translatable to patients with cancer. It is exciting to combine data that are routinely collected for clinical care (like CT scans) with molecular tumor features to ultimately get new insights that could improve prognosis. This R01 project leverages pre-surgical CT scan data and archived tumor specimens to help us understand how body size impacts clinical outcomes among kidney cancer patients.
  • Zhihong Gong, Ph.D.
    Roswell Park Cancer Institute Corp
    Cancer Epidemiology Researcher

    African American women have a greater risk of being diagnosed with high-grade, aggressive estrogen receptor-negative or triple-negative breast cancers, and have the highest mortality rates. But why? It is my passion to identify biological factors and underlying mechanisms contributing to this racial disparity.
  • Brian D. Gonzalez, Ph.D.
    H. Lee Moffitt Cancer Center & Research Institute
    Behavioral Oncology Scientist

    Preventable and treatable quality of life issues affect too many cancer survivors, particularly minority and underserved survivors. Discovering the impact of mHealth behavioral interventions has driven me to make these tools widely available to cancer survivors.
  • Ilana Graetz, Ph.D.
    University of Tennessee Health Science Center
    Health Services and Policy Researcher

    Healthcare matters for everybody - no one goes through life without having to deal with the healthcare system in a significant way. My family's experience in dealing with chronic health issues made me realize how deeply flawed the US healthcare system is, and I wanted my research to make a real difference to someone.
  • Heather Greenlee, N.D., Ph.D., M.P.H.
    Columbia University Medical Center
    Behavioral Scientist and Translational Epidemiologist

    I am inspired to do this work by the people in my life who have had a cancer diagnosis. In addition to knowing what cancer treatment they should receive, they want to know what they should eat, what kind of exercise they should do, and whether they should use any integrative therapies. At this point in time, we have many more questions than answers. We have a lot of work to do.
  • Xingyi Guo, Ph.D.
    Vanderbilt University Medical Center
    Bioinformatic and Cancer Genetic Epidemiology Scientist/Researcher

    Through many years of training in bioinformatics and collaborating with the prominent leaders in the cancer genetic epidemiology field, I have realized that the analysis of population-based genetic data using innovative bioinformatic and statistical approaches can advance our understanding of human disease and facilitate the translation of new findings to disease prevention and treatment.
  • Chad He
    Fred Hutchinson Cancer Research Center
    Biostatistician and Data Scientist

    My research program is greatly influenced by high-throughput genomic technology and modern computing power. These new technologies make it possible to sequence tumor samples at unprecedented scale and precision. My research aims to harness the power of these new technologies and develop computation efficient methods for the analysis of cancer data.
  • Chunyan He
    Indiana University - Purdue University Indianapolis
    Molecular and Genetic Epidemiologist

    My background in both molecular biology and epidemiology has given me a comprehensive knowledge of cancer at the molecular, as well as at the population level, and helped me to develop a unique understanding of the need to integrate basic science and epidemiological studies into cancer research.
  • Tina Hernandez-Boussard
    Stanford University
    Health Services Researcher

    I find that the manipulation and re-utilization of large datasets provide a goldmine for novel clinical research questions.
  • Brian L. Hitsman, Ph.D.
    Northwestern University
    Behavioral Scientist

    Although adults with mental health disorders have the most to gain from quitting smoking, they still are the least likely to have their nicotine dependence treated. In order to achieve a major reduction in smoking rates and health disparities, much more work needs to be done to help individuals with mental illness to stop smoking.
  • May Hua, M.D.
    Columbia University Health Sciences
    Anesthesiologist-Intensivist and Palliative Care Researcher

    During my critical care training, I realized that I was spending a lot of time learning how to use the most cutting-edge technology to prolong patients' lives, with much less focus on what happens when those interventions are unable to help patients survive. In medicine we tend to embrace the high-tech solutions, but sometimes what may help patients most are low-tech, humanistic approaches, like palliative care.
  • Megan J. Huchko, M.D.
    University of California - San Francisco
    Obstetrician/Gynecologist and Global Health Researcher

    The research community has made tremendous strides in demonstrating the efficacy of low-cost cancer prevention strategies for low-resource settings. However, I have realized that for these strategies to be truly effective, consideration of the contextual factors impacting the uptake and sustainability of these interventions in the target populations is crucial.
  • Shehnaz K. Hussain
    Cedars-Sinai Medical Center
    Molecular Epidemiologist Scientist/Researcher

    Infections and immune dysfunction are root causes for numerous burdensome cancers, and also provide us with targets for cancer prevention and control spanning the continuum from primary prevention to screening to early detection.
  • Robert M. Jacobson, M.D.
    Mayo Clinic Rochester
    Population Health Scientist/Researcher

    I saw a video teaching providers how to speak to parents about the HPV vaccine. An actor playing the provider demonstrated the silliness of presenting the polio vaccine to parents of infants the way providers think they must present HPV vaccines to parents of teens. The actor said something like this: "No one likes to think of their baby being the sort who would put another baby's fecal material in the mouth, but it happens." It illustrated for me a strong example of an effective recommendation.
  • Shu Jiang, Ph.D.
    Washington University in St. Louis
    Biostatistician

    I was struck by how powerful statistical and computational models can be in deciphering the complex and dynamic disease processes.
  • Fabian M. Johnston, M.D., M.H.S.
    Johns Hopkins University
    Surgical Oncologist and Health Care Disparities Researcher

    Martin Luther King said, "Of all the forms of inequality, injustice in health is the most shocking and the most inhuman because it often results in physical death." As a trainee I realized that there is a huge burden of disparities that burden our patients, but the most egregious to me is that a patient with advanced illness would now have the care at the end of their life be worse. I don't want to see this happen anymore, thus I seek health equity for all populations at the end of life.
  • Elizabeth D. Kantor, Ph.D., M.P.H.
    Memorial Sloan Kettering Cancer Center
    Cancer Epidemiologist

    I first became interested in public health when volunteering in a clinic in an impoverished community; although I could see that medical treatment was critical, I also realized that we needed to take a larger-picture view to prevent disease from occurring in the first place. At that point, I was sold on public health as a discipline and knew that I'd found my place.
  • Mira L. Katz
    Ohio State University
    Cancer Behavioral Scientist

    Meeting with community members about their fears and concerns about cancer made me recognize the importance of engaging the community early in the behavioral research process to reduce cancer health disparities.
  • Darla E. Kendzor, Ph.D.
    University of Oklahoma - Health Sciences Center
    Behavioral Scientist

    I had a realization that countless factors adversely impact the health of those living in poverty, and this has compelled me to work towards achieving health equity through behavior change.
  • Stacey Kenfield, Sc.D.
    University of California - San Francisco
    Cancer Epidemiology Researcher

    A cancer diagnosis is a teachable moment when individuals are motivated to change behavior to reduce risk of adverse health outcomes. This has led me to focus my research on elucidating the role of lifestyle factors in relation to patient-reported outcomes (e.g., quality of life, treatment side effects) and clinical outcomes (e.g., recurrence, mortality) in adults with cancer to improve quality of life, cancer prognosis, and overall health.
  • Ekta Khurana, Ph.D.
    Weill Cornell Medical College
    Computational Biologist/Genomics Researcher

    My research passion is to use my interdisciplinary training to tackle challenging questions in cancer research.
  • Andy J. King, Ph.D.
    Iowa State University
    Health Communication Scientist/Researcher

    Early detection of cancer can save lives and improve people's quality of life. There's a lot of misinformation and misunderstanding about cancer screening, and figuring out ways to help people make informed decisions about screening through cancer communication efforts is a worthwhile goal.
  • Anne C. Kirchhoff, Ph.D., M.P.H.
    University of Utah
    Health Services Researcher

    Navigating the complexity of health care and insurance is overwhelming for many cancer patients. Patients have to become their own advocates, while dealing with the health effects and stress of a cancer diagnosis. This can be particularly hard for adolescent and young adult cancer patients, who typically have little experience with insurance complexities prior to diagnosis.
  • Candyce H. Kroenke, M.P.H., Sc.D.
    Kaiser Foundation Research Institute
    Social and Cancer Epidemiologist

    My ah-ha moments have included all of those times I have noted striking differences in aging and health among people of the same chronological age, as well as how social networks create 'luck.' Opportunistically, I noted that most work on social networks and health outcomes was conducted in cardiovascular disease and saw a need to develop this work in cancer. Moreover, because sociodemographic factors govern the social environment, this naturally led to interest in health disparities.
  • Mark J. Landau
    University of Kansas - Lawrence
    Social Psychologist and Behavioral Scientist

    I'm continually fascinated by the notion that metaphor operates at a conceptual (not just linguistic) level to shape thinking, feeling, and behavior, and it's time to apply that notion to understand how people conceive of cancer and their power to reduce their risk.
  • Simon Lee
    University of Texas Southwestern Medical Center
    Medical Anthropologist and Health Services Researcher

    An early R03 enabled me to conduct serial ethnographic interviews with lung cancer patients and family caregivers in their homes in South Dallas. Taking a breath through his oxygen mask, one patient with a Stage III diagnosis caught me by surprise saying something like, "Dr. Lee, diabetes is the worst thing that can happen to a fellow." That was the moment I realized I needed to study cancer as one of multiple chronic conditions that people are managing in their complex lives.
  • Sara Lindstroem
    Harvard University - T.H. Chan School of Public Health
    Genetic Epidemiologist

    During my postdoctoral fellowship, we identified a gene that influenced both the composition of breast tissue and the risk of developing breast cancer. These findings made me realize that genetics can link diseases with other traits. My goal is to obtain a better understanding of the genetics behind such connections, as I believe it can ultimately lead to improved strategies for diagnosis and treatments of human disease.
  • Carissa A. Low, Ph.D.
    University of Pittsburgh
    Health Psychologist

    Listening to the stories of the patients I worked with during my clinical training, I realized that the hour I spent with them at the Cancer Center offered a very limited glimpse into each individual's most valued activities, daily routines, and social relationships. Smartphones and other mobile devices can provide new insights into these real-world behaviors and allow us to track changes in functioning and health that may be valuable to both patients and providers.
  • Qian Lu, M.D., Ph.D.
    University of Houston
    Behavioral Scientist and Health/Social Psychologist

    Around the time I completed my medical training, I came across a life-changing article in Science magazine by G.L. Engel that addressed the limitations of the biomedical model of disease and how it left no room in its framework for the social, psychological, and behavioral dimensions of an illness. Since then, a biopsychosocial model has guided my research, teaching, and approach to patient care.
  • Todd Lucas, Ph.D.
    Michigan State University
    Health Psychology Researcher

    Southeast Michigan has been the setting of my scholarly training as well as my career , and this context has greatly informed my sensitivity to the importance of justice for individuals and communities, and my appreciation for the potential that justice holds as a psychological solution to health and social problems.
  • Kathleen D. Lyons, Sc.D., O.T.R.
    Dartmouth-Hitchcock Medical Center
    Rehabilitation Scientist

    I watched a colleague present a conceptual model of an oncology care intervention and he included "functional status" in the list of unmodifiable patient variables, along with age and disease site. That was the moment I truly understood the unique perspective and potential of rehabilitation science to enhance oncology care.
  • Jennifer W. Mack, M.D., M.P.H.
    Dana-Farber Cancer Institute
    Outcomes Researcher

    The most profound influence on my work was my mentor, Dr Jane Weeks, who taught me that doing research, and working with the smartest, most interesting, most fun people, can be one of the great joys of life.
  • Nicholas Mancuso, Ph.D.
    University of Southern California
    Statistical Genetics Scientist/Researcher

    During my postdoctoral training, I became fascinated by computational approaches demonstrating that by anchoring molecular phenotypes on germline genetics, we can improve our ability to identify susceptibility genes and their regulatory mechanisms. My current research aims to extend this line of thinking to diverse populations and molecular phenotypes to identify susceptibility genes for prostate cancer.
  • Darren M. Mays, Ph.D., M.P.H.
    Georgetown University
    Behavioral Cancer Prevention Researcher

    My background as a public health scientist has inspired me to conduct research that is aimed for population-level impact by focusing on developing effective cancer prevention communication messaging. Some of the most common risk behaviors that are linked with cancer, like tobacco use, sun exposure, and indoor tanning, tend to develop at an early age but are highly preventable. I study how to promote cancer preventive behaviors by designing communication messages that resonate with young people and motivate healthy choices.
  • Susan R. Mazanec, Ph.D., R.N., A.O.C.N.
    Case Western Reserve University
    Nurse Scientist

    Family caregivers, who have shared their needs, concerns, and experiences with me, have inspired my program of research. My "ah-ha" moment for my current research came during a brief, open house tour of the simulation center at our school of nursing. It was amazing to watch the technical demonstrations using high-fidelity simulators and to learn about the methodology used in nursing education. As I left the center, I asked myself, "Could simulation help our family caregivers?"
  • Valerie McCormack, Ph.D., M.Sc.
    International Agency for Research on Cancer
    Cancer Epidemiology Researcher

    During every visit to Africa, I'm struck by the cultural, lifestyle, and environmental diversity and the massive expanse of countries. These lead to challenges for cancer diagnosis and treatment, but also to the most interesting studies on cancer aetiology.
  • Brenna C. McDonald, Psy.D., M.B.A., A.B.P.P.
    Indiana University School of Medicine
    Clinical Researcher

    I was first directly exposed to fMRI maps when interviewing for fellowships over 20 years ago. Actually seeing activation of the motor strip exactly where it "should" be in the brain gave me my first real glimpse of the potential power of the technology for exploring brain-behavior relationships and understanding cognitive dysfunction, which has been the focus of my research for the past two decades.
  • Douglas Mennin, Ph.D.
    Teachers College, Columbia University
    Clinical Psychological Scientist/Researcher

    In the face of difficult circumstances and struggles, so many people suffer in the distress of their own minds. Challenging contexts such as receiving a cancer diagnosis or caring for a loved one with cancer can come with the added burden of internal distress. The purpose of my research has been to elucidate how to best alleviate this suffering, transcend these burdens, and take action towards what is meaningful despite uncertainty, grief, and fear.
  • David C. Miller, M.D., M.P.H.
    University of Michigan
    Cancer Surgeon and Health Services Researcher

    Solving the problems of individual patients with cancer was my primary motivation for becoming a surgeon. At the same time, I am optimistic that my research will serve as a "force multiplier" that improves health care and health outcomes not only for my individual patients, but-just as importantly-for diverse populations that I will never meet.
  • Jeffrey W. Miller, Ph.D.
    Harvard University - T.H. Chan School of Public Health
    Statistician/Genomics Researcher

    When I learned about the complexity of patterns exhibited by mutations across the genome in cancer, I was struck by the potential for combining prior biological knowledge with structured probabilistic models to detect and analyze cancers.
  • Kimberly A. Miller, Ph.D., M.P.H.
    University of Southern California
    Behavioral Scientist

    Young adulthood is often an incredibly challenging time. Adding a cancer diagnosis can make this life stage exponentially more difficult. Adolescent and young adult (AYA) cancer survivors require tailored, age-appropriate supportive care services to maintain high physical, mental and social quality of life. My hope is to identify the clinical and lifestyle interventions that AYA cancer survivors want to ensure healthy survivorship for this distinct group.
  • Ritesh I. Mistry, Ph.D.
    University of Michigan
    Behavioral Scientist and Cancer Prevention Researcher

    Being an immigrant, early on it seemed apparent to me that the country a person lives in and who they live with have profound impacts on their life. The mission of my career is to study how these contexts impact cancer risk behaviors.
  • Erika L. Moen, M.S., Ph.D.
    Dartmouth College
    Health Data Scientist and Health Services Researcher

    Upon seeing a map associated with the American Society of Clinical Oncology's report on oncology workforce shortages, I realized that I could improve our understanding of access to specialty care in a way that recognizes the importance of interdisciplinary relationships by integrating network analysis, geography, and workforce data.
  • Xiaoli Nan, Ph.D.
    University of Maryland, College Park
    Communication and Behavioral Scientist

    My research suggests that people are both highly resistant and susceptible to persuasion. Science-informed persuasive strategies hold the key to developing cost-effective, ethical interventions for health behavior change
  • Kerrie P. Nelson, Ph.D., M.S., B.Sc.
    Boston University Medical Campus
    Biostatistician

    My undergraduate training introduced me to the use of statistics in medical studies, and compelled me to see the novel, exciting and challenging opportunities for biostatisticians as part of a team of researchers.
  • Suzanne C. O'Neill
    Georgetown University
    Behavioral Scientist and Clinical Health Psychologist

    My graduate training coincided with the publication of many of the first studies of the psychosocial and behavioral impact of cancer genetic susceptibility testing. I became increasingly interested in applying my expertise in stress and coping research to studying how individuals interpret, apply and cope with individualized cancer risk information.
  • Amber L. Pearson, Ph.D., M.P.H., M.Sc.
    Michigan State University
    Health Geographer

    I first became interested in how neighborhood green spaces may improve health through my work in New Zealand, where green spaces tend to be high quality and accessible. Now I live in Michigan, where Detroit is recovering from decades of disinvestment in its parks. While improvements have been made, neighborhoods remain where the city's parks renaissance has not reached. This study allows us to test how restoring parks to be vibrant green spaces may contribute to health in underserved communities.
  • Dorothy W. Pekmezi, Ph.D.
    University of Alabama at Birmingham
    Behavioral Scientist/Researcher

    The most profound influences on my research program have come from clinical encounters and qualitative research, in which patients/participants are often eager to eat healthier and exercise more but describe real barriers to accessing related programs/resources (costs, transportation, etc.) and desire encouragement and accountability.
  • Kathryn L. Penney, Sc.D.
    Brigham and Women's Hospital
    Genetic and Molecular Epidemiologist

    I have always had diverse research interests across molecular biology and population science. When I realized that integrating different types of data, including germline genetics, tissue composition, molecular characteristics, epidemiologic factors, and clinical outcomes, would create a more comprehensive picture of the disease to improve the understanding of etiology and progression, the focus of my research came together.
  • Andrew D. Plunk, Ph.D.
    Eastern Virginia Medical School
    Ethicist and Social Epidemiologist

    I've done interesting and scientifically important work with large datasets that never involved having to talk to a real person, but it wasn't until I started to use mixed methods and partnering with a community advisory board that I felt like my work could actually matter. I remember feeling completely humbled the first time a lay community member's feedback helped me understand what the data were trying to tell me, but which I had been unable to see.
  • Hermine Poghosyan, Ph.D., M.P.H.
    Northeastern University
    Cancer Epidemiology and Survivorship Researcher

    Tobacco use, which is the leading cause of preventable premature death worldwide, affects too many cancer survivors, their families, and friends. My goal is to find ways to better promote smoking cessation among individuals who have received a cancer diagnosis and their social network members, including families, friends, and others.
  • Pallav Pokhrel, Ph.D., M.P.H.
    University of Hawaii at Manoa
    Behavioral Scientist/Health Behavior Researcher

    The advent of e-cigarettes has marked an epoch in the history of smoking-their impact on public health needs to be studied and studied clear-headedly.
  • Lisa M. Quintiliani, Ph.D.
    Boston Medical Center
    Behavioral Scientist/Researcher

    My "ah-ha" moment came as a first year PhD student, when my mentor Dr. Marci Campbell invited me to eastern North Carolina to attend my first community-based research meeting. That was my first time seeing community-based research in action; lessons I have been applying to my research ever since.
  • Megha Ramaswamy, Ph.D., M.P.H.
    University of Kansas School of Medicine
    Sociologist and Applied Public Health Researcher

    Looking back, it was my early curiosity about inequality (kindled by a childhood in the Deep South and bedtime discussions with my dad about racism and politics) that ultimately motivated me as an adult to tackle the health disparities that affect marginalized women and men.
  • Andrew D. Ray, P.T., Ph.D.
    Roswell Park Cancer Institute Corp
    Physical Therapist and Exercise Physiology Scientist/Researcher

    I always knew there was something special about my work, but it wasn't until I presented my findings to a neighboring University I realized how strong my pilot data really was.
  • Maija A. Reblin, Ph.D.
    H. Lee Moffitt Cancer Center & Research Institute
    Social and Health Psychologist

    Early in my career, I was lucky to have access to naturalistic recordings of families coping with cancer at home. Listening to those participants' lives and stories has had the most profound impact on my program of research. It helps me to know what's important, but also some of the voices and experiences have just stuck with me over time.
  • Diana Redwood, Ph.D.
    Alaska Native Tribal Health Consortium
    Cancer Prevention and Control Scientist/Researcher

    Coming from a background in public health, I am continually reminded that there is no single health promotion solution that works for all. Rather, we must always be exploring different methods and new technologies to help people move towards better health.
  • Paul L. Reiter
    Ohio State University
    Behavioral Scientist and Epidemiologist

    I have always had a strong interest in improving health at the population level and reducing health disparities, and I believe that behavioral interventions can be an important tool for achieving these goals.
  • Alana M. Rojewski, Ph.D.
    Medical University of South Carolina
    Psychologist and Tobacco Treatment Researcher

    The first time I saw a patient with an IV pole smoking on the sidewalk outside of the hospital, it stopped me in my tracks. Here was a person who was facing significant health challenges from their smoking and still could not quit. If this health event was not enough of a motivation, then I would make it my mission to design interventions to help them successfully quit.
  • Shyanika W. Rose, Ph.D., M.A.
    University of Kentucky
    Tobacco Control and Health Equity Researcher

    I believe that it is not enough to study a problem or even to identify a solution. I am motivated to develop the evidence base that will support communities in developing policies and programs to meet their own needs and that center equitable outcomes for those most burdened by tobacco-related morbidity and mortality.
  • Rajani S. Sadasivam, Ph.D.
    University of Massachusetts Medical School
    Digital Heath and Population Health Scientist/Researcher

    I tested computer-tailored health communication (CTHC) techniques I learned in a 2007 workshop in a nationwide randomized control trial with 900 smokers. The system worked, and I realized the power of CTHC to help patients. During this time, companies like Amazon were using big data methods to adapt to users' continuous feedback (their collective intelligence) to tailor content. I realized that these methods could make CTHC even more powerful, and I have pursued this line of research since then.
  • Daniel Schauer, M.D.
    University of Cincinnati College of Medicine
    Clinician and Outcomes Researcher

    In my years of training I saw over and over that patients struggled to make major medical decisions and lacked the hard data to support their choices. With my passion for statistics and research, I realized that I could provide data points and build tools that would help people feel confident about their medical decisions.
  • Jessica Scott, Ph.D.
    Memorial Sloan Kettering Cancer Center
    Exercise Scientist

    Through interdisciplinary collaborations, I learned the research I was conducting at NASA to monitor and prevent toxicities in astronauts was very applicable to cancer patients. This motivated me to explore whether the tools and techniques used by NASA to offset spaceflight-related toxicity could be applied to improve long-term health and quality of life in cancer patients impacted by therapy-related toxicities.
  • Veena Shankaran, M.D.
    Fred Hutchinson Cancer Research Center
    Health Services and Cancer Health Economics Researcher

    chemotherapy and nausea medications due to the cost - it broke my heart to see this poor man's care compromised because he could not afford treatment. From that moment, I decided to study how and why cancer care is so expensive and financially toxic and figure out ways to help patients and families get the care they need without going broke.
  • Megan J. Shen, Ph.D.
    Weill Cornell Medical College
    Social Psychology and Communications Researcher

    In thinking about a major decision of my own, I realized that almost all major decisions including medical ones are often run by one's social network for feedback in the decision-making process; this opened my eyes to the fact that many patients use this same process in making decisions around their end-of-life care and need the proper support tools to guide them.
  • Cardinale B. Smith, M.D., Ph.D.
    Icahn School of Medicine at Mount Sinai
    Oncologist, Palliative Medicine Physician, And Healthcare Disparities Researcher

    My father, an Afro-Latino male, was diagnosed with metastatic rectal cancer at the age of 52. He developed pain, and when we tried to fill his opioid prescriptions, we found that the local pharmacies in his Brooklyn, NY, neighborhood either did not carry the opioids, refused to order it for him, or accused him of diversion when attempting to fill the prescription a day early. This experience of racism/bias was the catalyst for my research pursuits to achieve health equity.
  • Rebecca Smith-Bindman, M.D.
    University of California - San Francisco
    Clinician and Comparative Effectiveness Researcher

    We have had some very exciting preliminary results in helping hospitals standardize their practice. However, some sites were less than responsive to our feedback (either because they did not trust the results or did not perceive dose optimization to be a priority). This helped me realize that in order for practices to change, institutions need to have not only the tools and expertise to make a change, but also the will to do so.
  • Claire A. Spears, Ph.D.
    Georgia State University
    Psychologist and Health Disparities Researcher

    Practicing mindfulness has made a real difference in my life. Unfortunately, most of the research on mindfulness has not included very diverse populations, and I am committed to making mindfulness training more widely available to people from all walks of life. Using mobile technology could be one way to provide mindfulness training to low-income smokers who are interested in quitting smoking.
  • Stephanie Staras, M.S.P.H., Ph.D.
    University of Florida
    Population Health Scientist

    The moment when my first-born got his first set of vaccines - I got it. I had just caused my sweet son, whom I had been trying around-the-clock to keep from crying, to make a blood-curdling cry. It hit me - parents who are hesitant about vaccines are just scared. My logical brain said the shots were the best thing to protect my child, but my maternal-self screamed no. At that moment, I knew more must be done to help parents understand the importance of vaccines.
  • Irina Stepanov, Ph.D.
    University of Minnesota
    Analytical Biochemist and Cancer Researcher

    I have been very fortunate to be mentored by and collaborate with the prominent leaders in tobacco carcinogenesis research. Their example and guidance, along with my personal motivation to contribute to the prevention of suffering caused by cancer, shaped my research interests and direction.
  • Natasha K. Stout
    Harvard Pilgrim Health Care, Inc.
    Decision Scientist and Health Services Researcher

    For breast cancer screening, the growing recognition of anxiety and stress related to false positive test results and unnecessary biopsies highlights how more is not necessarily better. Decision modeling coupled with population-based data on real world outcomes can help us understand the benefits and risks associated with different screening approaches, as well as identify effective strategies to improve population health.
  • Virginia C. Sun
    Beckman Research Institute of City of Hope
    Oncology Nurse and Nurse Scientist

    As an oncology nurse, I have often wondered what was happening to our patients and families while waiting for surgery, while recovering at home, and how their unmet needs contribute to poor postoperative recovery and outcomes. From a patient- and family-centered perspective, cancer surgery populations are understudied and underrepresented. We need more interdisciplinary, evidence-based approaches to support patient postoperative recovery and family caregiving.
  • Kevin M. Sweet, M.S., L.G.C.
    Ohio State University
    Genetic Counselor and Clinician Researcher

    With the rapid and ongoing developments associated with genetic testing, especially for actionable diseases such as cancer, I see ever greater need for more patient-driven approaches and direct access to genetic counselors who can help maximize the effectiveness of the genetic testing process and provide a guiding hand.
  • Andy Tan, Ph.D., M.P.H., M.B.A., M.B.B.S.
    Dana-Farber Cancer Institute
    Health Communication Researcher

    My research is influenced by the foundational work on structural influences of communication inequalities (Viswanath), tobacco-related health disparities (Fagan), and minority stress and resilience model (Meyer).
  • Natasha Tasevska
    Arizona State University - Tempe
    Nutrition Scientist and Nutritional Epidemiologist

    Sugars are one of the most controversial nutritional topics today. Thus, we need validated and objective tools to accumulate strong scientific evidence to obtain the right answers.
  • Caroline A. Thompson, Ph.D., M.P.H.
    San Diego State University
    Cancer Epidemiologist and Population Health Scientist

    I spend a lot of time thinking about the cancer patient journey and how it can be classified and quantified from healthcare data in order to understand and improve outcomes across populations.
  • Johannes Thrul, Ph.D.
    Johns Hopkins University
    Addiction and Mobile Health Researcher

    I am excited about the potential of mobile health methods to test mechanisms of action and "active ingredients" of behavioral interventions.
  • Emily Tonorezos, M.D., M.P.H.
    Memorial Sloan Kettering Cancer Center
    Physician Scientist

    I am deeply gratified for the opportunity to help this unique population through both clinical care and research, as childhood cancer survivors have ongoing health needs that are not being met.
  • Jennifer Tsui, Ph.D., M.P.H.
    University of Southern California
    Cancer Control and Health Services Researcher

    Early in my career, I was fortunate to work with cancer control leaders researching HPV vaccine introduction. This inspired me to address inequities in preventable cancers and tackle complex health system, policy, and structural factors that limit access to new cancer prevention and treatment tools in diverse communities. My passion is to conduct implementation science and cancer care delivery research to improve cancer outcomes at the population level and reduce disparities.
  • Connie M. Ulrich
    University of Pennsylvania
    Nurse Bioethicist and Nurse Scientist/Bioethics Researcher

    Interviewing participants enrolled in cancer clinical trials greatly influenced my decision to design my study to learn more about their perceptions of the benefits and burdens of cancer clinical trials, how these relate to their decision to remain in their trials, and other related factors. I have also had the great honor to work, collaborate, and study under prolific interdisciplinary scholars who have guided my research trajectory in bioethics
  • Erin L. Van Blarigan, Sc.D.
    University of California - San Francisco
    Public Health Scientist/Researcher

    Cancer survivors' experiences and perspectives have a profound influence on my program of research.
  • Maya Vijayaraghavan, M.D., M.A.S.
    University of California - San Francisco
    Clinician Investigator

    I am deeply motivated by my patients and all our study participants who have contributed to our studies, shared experiences from their lives, and have taken an active part in developing and implementing our interventions. This work would not be possible without their partnership.
  • Christine Vinci, Ph.D.
    H. Lee Moffitt Cancer Center & Research Institute
    Behavioral Scientist/Researcher

    There are moments in time when the experience of distress can be overwhelmingly challenging and, as a result, negatively impact behavior. I hope my research can provide guidance as to what strategies and interventions can best support people when experiencing such distress.
  • Olivia A. Wackowski, Ph.D., M.P.H.
    Rutgers University - School of Public Health and Cancer Institute of New Jersey
    Public Health and Health Behavior Scientist/Researcher

    As a college student I remember being moved and inspired by the new, innovative and hard-hitting visuals and messages from the first wave of the national anti-smoking "Truth" campaign - I knew then that public health and tobacco control was something I wanted to focus on and be a part of.
  • Wenyi Wang, Ph.D.
    MD Anderson Cancer Center
    Statistician and Data Scientist

    My passion for applying statistical modeling to genomic studies, with a focus on clinical utilities for complex human diseases such as cancer, stems from my training in biology and statistics, and the realization that creating a dialogue between the two fields can vastly improve our understanding of disease.
  • Shaneda Warren Andersen, Ph.D.
    University of Wisconsin - Madison
    Epidemiologic Researcher

    A profound influence on my research program is the observed cancer health disparities among certain populations in the U.S. I am particularly interested in achieving health equity in colorectal cancer for vulnerable subpopulations who are less likely to undergo colorectal cancer screening: African Americans, individuals of low socioeconomic status, and adults under age 50.
  • Erika A. Waters
    Washington University in St. Louis
    Social and Health Psychologist

    My passion for primary prevention stems from witnessing firsthand the devastating consequences of engaging in unhealthy behaviors. However, it wasn't until my postdoctoral experience, which provided the opportunity to learn the multitude of ways that other disciplines approach the same problem, that I realized the importance of involving many disciplinary perspectives in my own work.
  • Karen J. Wernli, Ph.D., M.S.
    Kaiser Foundation Research Institute
    Cancer Epidemiologist and Health Services Researcher

    I was in this field for many years, before I experienced the loss of a family member due to cancer. Watching her cancer experience and the impact on our family, I realized that several treatment decisions are driven by the need to do something, when really nothing else can be done for a patient. I knew then that I wanted my research to directly impact cancer care that is timely, relevant, and compassionate. For me now, it is the collection of several personal experiences that drive my research.
  • Karen Wilson, M.D., Ph.D.
    University of Colorado School of Medicine
    Pediatric Clinical Tobacco Researcher

    I realized when I was talking to parents of children who were in the hospital that while this is an incredibly stressful event in their lives, it also opens up avenues for communication and motivation to quit smoking that they often don't have in the rush of their normal lives. We have an opportunity to help parents and children at a time when they are perhaps most open to positive change, and help both lead healthier lives.
  • Julie Anna Wolfson, M.D., M.S.H.S.
    University of Alabama at Birmingham
    Pediatric Oncologist and Health Services Researcher

    Fresh out of fellowship and beyond, my very wise mentor insisted that I do all of my own analyses. When I first saw my hypotheses come alive in the numbers on my screen, I may have jumped out of my seat with both excitement and dismay that it was true. I was drawn irreversibly into the world of research. I had to understand the "why" and to "fix it."
  • Yelena P. Wu, Ph.D.
    Huntsman Cancer Institute - University of Utah
    Behavioral Scientist/Pediatric Psychologist

    Childhood ultraviolet radiation exposure and sunburns are key modifiable risk factors for development of skin cancers, such as melanoma, later in life. However, there are few skin cancer prevention programs targeting adolescents, including in schools, that focus on teen intentional tanning and sun protection behaviors.
  • Hui Xie
    University of Illinois at Chicago
    Biostatistician and Data Scientist

    I am fascinated by the capabilities of new real-time data-capturing methods to improve behavioral research. I am excited to be developing appropriate analytic techniques and computational tools for use with these new kinds of data and emerging research approaches.
  • Lusine Yaghjyan, Ph.D.
    University of Florida
    Cancer Molecular Epidemiologist

    Ever since medical school, I have always believed that disease prevention, rather than focusing only on treatment, should be our ultimate goal. As I was reading for the first time about breast stem cells, I became fascinated with the complexity of their functions and potential, and realized how little we knew about their contributions to the early stages of breast carcinogenesis. Since then, I have been exploring how we could use them to advance breast cancer prevention.
  • Yuanqing Ye, Ph.D.
    MD Anderson Cancer Center
    Statistical Geneticist

    I'm fascinated by the potential application of mathematical, statistical, and computational approaches to the analysis of big data. I think these methods may revolutionize our research and advance the scientific understanding of human health and disease
  • Zhijun Yin, Ph.D.
    Vanderbilt University Medical Center
    Computer Scientist

    I believe the data, or the evidence hidden in the data, is the key to understanding public health as well as personal well-being. While new technologies have dramatically changed the world, the nature of social interaction and isolation of human beings is deemed to be a key factor when decoding such evidence.
  • Lydia B. Zablotska, M.D., M.P.A., Ph.D.
    University of California - San Francisco
    Epidemiologist and Radiation Scientist

    Seeing fears and frustration due to lack of clear scientific information about the effects of radiation exposures in patients suffering from the effects of the Chernobyl accident fired my passion for radiation research and for communicating scientific research findings to the general public.
  • Bradley J. Zebrack, Ph.D., M.S.W., M.P.H.
    University of Michigan - Ann Arbor
    Social Scientist / Researcher

    The emergence of new clinical care programs for AYAs and survivorship programs like First Descents, TeenCancerAmerican, and StupidCancer that specifically address the myriad and unique needs of AYAs inspires my program of research. Many of these programs have been established by AYA cancer survivors for the purpose of supporting other young people affected by cancer.
  • Lisa Zubkoff, Ph.D.
    Dartmouth College
    Implementation Scientist and Health Services Researcher

    Early in my career, I learned about the gap between what we know in healthcare and what we do. Understanding this gap is what led to my interest in the field of implementation science.
  • Heather T. Gold
    New York University School of Medicine
    Project Investigator

    Dr. Gold came to this field of research through studying disparities in breast cancer care. Not only are treatment patterns and outcomes affected by socioeconomic and racial/ethnic inequities in care, but underlying comorbidities, separate from cancer, may be influencing cancer care. This confluence of factors, from environmental, health system and individual, is hard to tease apart, yet this study aims to do just that.
  • J T. Hays
    Mayo Clinic Rochester
    Physician Clinical Investigator

    My patients inspire me to find the best way to free them from the grip tobacco has on their lives.